About Company
Founded in 2014 and headquartered in Emeryville, California, 4D Molecular Therapeutics is dedicated to unlocking the full potential of genetic medicine through its proprietary platform known as Therapeutic Vector Evolution. This platform enables the design and development of customized adeno-associated virus (AAV) vectors that are optimized for specific tissues and diseases. The company follows a "disease first" approach to product discovery and development, which allows for targeted delivery of therapeutic payloads.
Key Areas of Focus
- Gene Therapy: Developing innovative AAV vectors to deliver genes specifically to target cells associated with various diseases.
- Therapeutic Development: Focusing on conditions in ophthalmology, pulmonology, and cardiology, aiming to provide transformative therapies that can potentially cure diseases.
- Research and Collaboration: Partnering with patient organizations and healthcare providers to better understand patient needs and refine therapeutic approaches.
4DMT's commitment to bold innovation and relentless execution positions it as a leader in the gene therapy field, striving to create effective treatments for both rare and large market diseases.oach to product discovery and development, which allows for targeted delivery of therapeutic payloads.